Literature DB >> 20336415

Rationale and methods for assessment of pain-depressed behavior in preclinical assays of pain and analgesia.

S Stevens Negus1, Edward J Bilsky, Gail Pereira Do Carmo, Glenn W Stevenson.   

Abstract

Pain-depressed behavior can be defined as any behavior that decreases in rate, frequency, duration, or intensity in response to a putative pain state. Common examples include pain-related decreases in feeding, locomotion and expression of positively reinforced operant behavior. In humans, depression of behavior is often accompanied by a comorbid depression of mood. Measurements of pain-depressed behaviors are used to diagnose pain in both human and veterinary medicine, and restoration of pain-depressed behavior is often a priority of treatment. This article describes two strategies for integrating measures of pain-depressed behaviors into preclinical assays of pain and analgesia. Assays of pain-depressed behaviors may contribute both to improved translational efficiency in analgesic drug development and to new insights regarding the mechanisms and determinants of pain and analgesia.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20336415      PMCID: PMC5788447          DOI: 10.1007/978-1-60327-323-7_7

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  22 in total

Review 1.  Central neural mechanisms that interrelate sensory and affective dimensions of pain.

Authors:  Donald D Price
Journal:  Mol Interv       Date:  2002-10

Review 2.  What should we be measuring in behavioral studies of chronic pain in animals?

Authors:  Jeffrey S Mogil; Sara E Crager
Journal:  Pain       Date:  2004-11       Impact factor: 6.961

3.  Anxiety-like behaviour in rats with mononeuropathy is reduced by the analgesic drugs morphine and gabapentin.

Authors:  Kerstin Roeska; Henri Doods; Kirsten Arndt; Rolf-Detlef Treede; Angelo Ceci
Journal:  Pain       Date:  2008-06-18       Impact factor: 6.961

Review 4.  Predictive validity of animal pain models? A comparison of the pharmacokinetic-pharmacodynamic relationship for pain drugs in rats and humans.

Authors:  G T Whiteside; A Adedoyin; L Leventhal
Journal:  Neuropharmacology       Date:  2008-01-12       Impact factor: 5.250

Review 5.  Pain assessment: global use of the Brief Pain Inventory.

Authors:  C S Cleeland; K M Ryan
Journal:  Ann Acad Med Singapore       Date:  1994-03       Impact factor: 2.473

Review 6.  The epidemiology of pain in depression.

Authors:  Jean-Pierre Lépine; Mike Briley
Journal:  Hum Psychopharmacol       Date:  2004-10       Impact factor: 1.672

7.  Effects of laparotomy on spontaneous exploratory activity and conditioned operant responding in the rat: a model for postoperative pain.

Authors:  Thomas J Martin; Nancy L Buechler; William Kahn; James C Crews; James C Eisenach
Journal:  Anesthesiology       Date:  2004-07       Impact factor: 7.892

8.  Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia.

Authors:  Richard H Gracely; Frank Petzke; Julie M Wolf; Daniel J Clauw
Journal:  Arthritis Rheum       Date:  2002-05

Review 9.  Evaluation of prescription opioids using operant-based pain measures in rats.

Authors:  Drake Morgan; Christy S Carter; Jameson P DuPree; Robert P Yezierski; Charles J Vierck
Journal:  Exp Clin Psychopharmacol       Date:  2008-10       Impact factor: 3.157

Review 10.  Pain-like behaviours in animals - how human are they?

Authors:  Gordon Blackburn-Munro
Journal:  Trends Pharmacol Sci       Date:  2004-06       Impact factor: 14.819

View more
  27 in total

1.  Effects of peripherally restricted κ opioid receptor agonists on pain-related stimulation and depression of behavior in rats.

Authors:  S Stevens Negus; Robert O'Connell; Ember Morrissey; Kejun Cheng; Kenner C Rice
Journal:  J Pharmacol Exp Ther       Date:  2011-11-29       Impact factor: 4.030

2.  The Effects of Morphine, Baclofen, and Buspirone Alone and in Combination on Schedule-Controlled Responding and Hot Plate Antinociception in Rats.

Authors:  Jenny L Wilkerson; Jasmine S Felix; Luis F Restrepo; Mohd Imran Ansari; Andrew Coop; Lance R McMahon
Journal:  J Pharmacol Exp Ther       Date:  2019-06-24       Impact factor: 4.030

3.  Effects of the noncompetitive N-methyl-d-aspartate receptor antagonists ketamine and MK-801 on pain-stimulated and pain-depressed behaviour in rats.

Authors:  T M Hillhouse; S S Negus
Journal:  Eur J Pain       Date:  2016-02-23       Impact factor: 3.931

4.  Effects of the δ opioid receptor agonist SNC80 on pain-related depression of intracranial self-stimulation (ICSS) in rats.

Authors:  S Stevens Negus; Marisa B Rosenberg; Ahmad A Altarifi; Robert H O'Connell; John E Folk; Kenner C Rice
Journal:  J Pain       Date:  2012-03-15       Impact factor: 5.820

5.  Lack of paclitaxel effects on intracranial self-stimulation in male and female rats: comparison to mechanical sensitivity.

Authors:  Luke P Legakis; John W Bigbee; S Stevens Negus
Journal:  Behav Pharmacol       Date:  2018-04       Impact factor: 2.293

6.  Effects of μ-opioid receptor agonists in assays of acute pain-stimulated and pain-depressed behavior in male rats: role of μ-agonist efficacy and noxious stimulus intensity.

Authors:  Ahmad A Altarifi; Kenner C Rice; S Stevens Negus
Journal:  J Pharmacol Exp Ther       Date:  2014-11-18       Impact factor: 4.030

7.  Assessment of locomotion in chlorine exposed mice by computer vision and neural networks.

Authors:  Aristotelis S Filippidis; Sotirios G Zarogiannis; Alan Randich; Timothy J Ness; Sadis Matalon
Journal:  J Appl Physiol (1985)       Date:  2011-12-29

8.  Effects of the fatty acid amide hydrolase inhibitor URB597 on pain-stimulated and pain-depressed behavior in rats.

Authors:  Andrew J Kwilasz; Rehab A Abdullah; Justin L Poklis; Aron H Lichtman; Sidney S Negus
Journal:  Behav Pharmacol       Date:  2014-04       Impact factor: 2.293

Review 9.  Electroencephalography and analgesics.

Authors:  Lasse Paludan Malver; Anne Brokjaer; Camilla Staahl; Carina Graversen; Trine Andresen; Asbjørn Mohr Drewes
Journal:  Br J Clin Pharmacol       Date:  2014-01       Impact factor: 4.335

10.  Effects of monoamine reuptake inhibitors in assays of acute pain-stimulated and pain-depressed behavior in rats.

Authors:  Marisa B Rosenberg; F Ivy Carroll; S Stevens Negus
Journal:  J Pain       Date:  2013-01-16       Impact factor: 5.820

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.